Push for regulatory framework on nicotine products intensify
National
By
Pkemoi Ng'enoh
| May 30, 2025

The Harm Reduction Society which is dedicated to the uptake of harm reduction interventions among communities has decried the delays to the Senate’s Tobacco Control Amendment Bill 2024.
According to the Society, the lack of a clear legal framework is fueling misinformation about alternative nicotine products, hindering their potential to reduce tobacco-related harm.
The Bill published in July 2024, was aimed at creating a legal framework for smokeless nicotine products, which are currently unregulated in Kenya.
“While there are issues with the Bill, we must move forward from the current stasis and begin progressing a regulatory structure for alternative nicotine products,” said Dr Michael Kariuki, Secretary-General of the Harm Reduction Society.
READ MORE
Standard Chartered partners with CISI to boost wealth management expertise
New airport system to boost safety
Oramah's new book foresees intra-African trade doubling in decade
Outgoing Afreximbank's president Oramah hailed as continental integration engine
China's Xiaomi unveils first EV, receives 289,000 pre-orders in minutes
Ruto signs Finance Bill into law as KRA faces Sh2.75tr revenue test
Report: How demand for donkey skin hurts livelihoods of women, children
New deal seeks to streamline fintech and bank integration in Kenya
Dahabshiil CEO honoured with global award
Property firms, telcos risk fines for locking out small internet firms from buildings
He added that while products like vapes have been in existence for 20 years, there is still no basic laws in Kenya to prevent them from being sold to underage.
“In the year since the bill was first published, Kenyans have faced a growing barrage of misinformation about the safety of nicotine products relative to cigarettes. That misinformation is preventing smokers from switching to reduced-risk products, which could save their lives,” said Kariuki
Adding that, “Smokers deserve clarity about the relative risks of smokeless nicotine products compared to smoking and their ability to reduce tobacco-related disease. This can only be achieved if the bill is accelerated.”
Reportedly, other countries that have introduced balanced regulatory systems for nicotine alternatives have seen their smoking rates plummet with vaping being attributed with helping three million smokers to quit in England in the last five years.
“Some 12,000 people die every year in Kenya from tobacco-related deaths,” said Dr Kariuki adding that there is need to urgently prioritise helping smokers who are struggling to quit to get off cigarettes once and for all.
“International evidence shows that nicotine products like vapes are the most effective tools to help smokers quit. Saving lives must be the priority.” Noted Kariuki
Pointing out, “What Kenya requires right now is balanced regulation of nicotine products that prevents under-18s access, while ensuring adult smokers have the best tools to help them quit their deadly habit.”